I don't think any sale for Calypte is meaningless. On the plus side, Russia is slowly becoming an emerging market and and currently Calypte has no competetion in regards to an oral OTC HIV test. If Calypte was good at selling their product, all it would take is one large Russian Retailer to sell it at their stores and boom. The chances of this happening? not sure... I am not familiar with Russia's stance in regards to the OTC test. Would have to do some dd.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.